Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

A new gene, JMJD1C, may affect testosterone levels in men.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Using finasteride with TIP extends time off period for prostate cancer patients.

The most common causes of hair loss in Jordanian children are fungal infections, autoimmune hair loss, and hair shedding after fever, with zinc deficiency also being a notable cause.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.